We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
+5.09%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$4.2B
AUM Growth
+$14.3M
Cap. Flow
-$171M
Cap. Flow %
-4.06%
Top 10 Hldgs %
15.3%
Holding
597
New
24
Increased
135
Reduced
349
Closed
47

Top Buys

Rank Stock Value
1
FNB icon
FNB Corp
FNB
+$28.2M
2
NXPI icon
NXP Semiconductors
NXPI
+$24.1M
3
SIAL
SIGMA - ALDRICH CORP
SIAL
+$11.4M
4
AAPL icon
Apple
AAPL
+$10.7M
5
MG icon
Mistras Group
MG
+$10.5M

Sector Composition

Rank Sector Weight
1 Healthcare 16.84%
2 Industrials 14.37%
3 Technology 11.34%
4 Consumer Discretionary 11.08%
5 Financials 9.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SHW icon
226
Sherwin-Williams
SHW
$78.3B
$3.35M 0.08%
48,513
-1,200
-2% -$80.1K
OXY icon
227
Occidental Petroleum
OXY
$57B
$3.24M 0.08%
32,988
-1,138
-3% -$107K
PLPC icon
228
Preformed Line Products
PLPC
$1.52B
$3.13M 0.07%
58,111
-5,310
-8% -$303K
OKE icon
229
Oneok
OKE
$58.7B
$2.96M 0.07%
43,491
-4,780
-10% -$302K
LUMN icon
230
Lumen
LUMN
$6.53B
$2.89M 0.07%
79,881
-5,538
-6% -$199K
MAGN
231
Magnera Corp
MAGN
$488M
$2.87M 0.07%
+8,334
New +$2.84M
VZ icon
232
Verizon
VZ
$194B
$2.83M 0.07%
57,892
-10,678
-16% -$517K
OII icon
233
Oceaneering
OII
$5.25B
$2.8M 0.07%
+35,894
New +$2.63M
SYK icon
234
Stryker
SYK
$127B
$2.78M 0.07%
32,977
-2,900
-8% -$237K
FURX
235
DELISTED
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
$2.69M 0.06%
25,326
-643
-2% -$63.1K
GILD icon
236
Gilead Sciences
GILD
$161B
$2.65M 0.06%
31,975
-5,470
-15% -$426K
T icon
237
AT&T
T
$165B
$2.63M 0.06%
98,390
-5,860
-6% -$157K
SNA icon
238
Snap-on
SNA
$20.9B
$2.58M 0.06%
+21,796
New +$2.52M
WMT icon
239
Walmart Inc
WMT
$871B
$2.52M 0.06%
100,707
-8,229
-8% -$211K
HD icon
240
Home Depot
HD
$332B
$2.5M 0.06%
30,906
-3,301
-10% -$260K
CORE
241
DELISTED
Core Mark Holding Co., Inc.
CORE
$2.44M 0.06%
107,076
-76,084
-42% -$1.56M
BEAV
242
DELISTED
B/E Aerospace Inc
BEAV
$2.41M 0.06%
35,923
-26,199
-42% -$1.74M
ABCB icon
243
Ameris Bancorp
ABCB
$5.89B
$2.35M 0.06%
108,845
-33,703
-24% -$727K
MTX icon
244
Minerals Technologies
MTX
$2.31B
$2.27M 0.05%
34,600
+19,578
+130% +$1.22M
BMY icon
245
Bristol-Myers Squibb
BMY
$127B
$2.26M 0.05%
46,580
-1,476
-3% -$72.7K
RSP icon
246
Invesco S&P 500 Equal Weight ETF
RSP
$96.1B
$2.24M 0.05%
29,166
-6,044
-17% -$448K
KMP
247
DELISTED
KINDER MORGAN ENER PNTRS L.P.
KMP
$2.22M 0.05%
27,014
-8,225
-23% -$635K
AVNW icon
248
Aviat Networks
AVNW
$262M
$2.19M 0.05%
285,346
+3,369
+1% +$25.9K
IWM icon
249
iShares Russell 2000 ETF
IWM
$80.9B
$2.15M 0.05%
18,124
-4,427
-20% -$503K
BCR
250
DELISTED
CR Bard Inc.
BCR
$2.1M 0.05%
14,686
-500
-3% -$71.4K

Similar funds

Segall Bryant & Hamill's Q2 2014 Portfolio in Review

As of Q2 2014, Segall Bryant & Hamill held 597 positions worth $4.2B, up 0.34% from $4.19B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Segall Bryant & Hamill withdrew a net $171M in Q2 2014, closing 47 positions and reducing 349 holdings. Its most notable exit was A T M I INC, an estimated $9.97M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 17% a quarter earlier, followed by Industrials and Technology.

Against the trend, Segall Bryant & Hamill opened a new position in FNB Corp worth $28.7M.

  • Segall Bryant & Hamill's largest Q2 2014 buy was FNB Corp: 2,236,624 shares worth $28.7M.
  • Segall Bryant & Hamill added most to Apple in Q2 2014, an estimated $10.7M increase.
  • Segall Bryant & Hamill's biggest Q2 2014 reduction was Allergan Inc, cutting an estimated $24.2M.
  • Segall Bryant & Hamill fully exited A T M I INC in Q2 2014, selling an estimated $9.97M.
  • Segall Bryant & Hamill's ten largest holdings make up 15% of its $4.2B portfolio in Q2 2014.
  • Segall Bryant & Hamill opened 24 new positions and closed 47 in Q2 2014.
  • Segall Bryant & Hamill's portfolio value rose 0.34% quarter-over-quarter to $4.2B.

Based on Segall Bryant & Hamill's 13F filing for Q2 2014, filed 14 Aug 2014.